Novartis and Ionis

Novartis Invests $60 Million Upfront in Ionis’ Innovative Cardiovascular Medication

Source – Ionis Pharmaceuticals Novartis has enlisted Ionis to develop another drug for cardiovascular disease, investing $60 million in a ...